Clinical and Biological Characterization of Post COVID-19 Syndrome

NCT05735782 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2023-02-21

No results posted yet for this study

Summary

The goal of this observational study is to describe the symptoms that persist for more than 12 weeks after the acute episode in participants who had COVID-19, and compare the functional, socioeconomic and occupational effects with a post-COVID-19 control group without persistent symptoms after the COVID-19 acute event.

The main questions it aims to answer are:

* What are the characteristics of symptoms that persist for more than 12 weeks in participants who have had COVID19 in the last year?
* What are the health-related quality of life and psychosocial effects in participants with persistent symptoms of COVID-19, compared to a post-COVID-19 control group without persistent symptoms after the acute episode of COVID-19?

Conditions

Interventions

DIAGNOSTIC_TEST

Clinical, mental health and psychosocial profile of Post-COVID-19 syndrome

Evaluation of persistent symptoms of COVID-19 and its association with psychological, cognitive and social status in comparison to a healthy control group

DIAGNOSTIC_TEST

Diagnostic performance of echocardiographic and biological markers in Post-COVID-19 syndrome

Determine the inflammatory, immune profile and ventricular function in post-COVID-19 participants compared to a control group

Sponsors & Collaborators

  • Hospital El Cruce

    collaborator OTHER
  • National University of Cuyo

    collaborator OTHER
  • Universidad Nacional de La Plata

    collaborator OTHER
  • University of Buenos Aires

    collaborator OTHER
  • Arturo Jauretche National University

    lead OTHER

Principal Investigators

  • Laura Antonietti, MD, MHA · Arturo Jauretche National University

  • Javier Mariani, MD · Hospital El Cruce

  • Walter Manucha, PhD · National University of Cuyo

  • Mariela Paz, PhD · University of Buenos Aires

  • Martín Rumbo, PhD · Universidad Nacional de La Plata

  • Liliana Dain, PhD · University of Buenos Aires

  • Carlos Tajer · Hospital El Cruce

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-16
Primary Completion
2023-04-30
Completion
2023-06-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05735782 on ClinicalTrials.gov